(Q33186052)

English

Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Alexander Eggermont

1

object named as

Alexander M M Eggermont

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Timo L M ten Hagen

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Current Oncology Reports

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

79-80

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF is here to stay--revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/12583823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11912-003-0091-X

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33186052&oldid=2195132329"